Marcus Jack Swann

Dr. Marcus Jack Swann

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2010 in Analytical Chemistry
Verified
Journal Article
Closed access
JWJuan Wang
Juan Wang
PCPaul D. Coffey
Paul D. Coffey
MSMarcus Jack Swann
Marcus Jack Swann
Fan YangFan Yang
Fan Yang
JLJian R Lu
Jian R Lu
XYXiurong Yang
Xiurong Yang

1 August 2023 in The Analyst
Verified
Journal Article
Open access
PDF file
VMVijayalaxmi Manoharan
Vijayalaxmi Manoharan
RRRui Rodrigues
Rui Rodrigues
SSSara Sadati
Sara Sadati
MSMarcus Jack Swann
Marcus Jack Swann
NFNeville Freeman
Neville Freeman
JCJerome Charmet
Jerome Charmet
Electrochemical sensing is ubiquitous in a number of fields ranging from biosensing, to environmental monitoring through to food safety and battery or corrosion characterisation. Whereas conventional potentiostats are ideal to develop assays in laboratory settings, they are in general, not well-suited for field work due to their size and power requirements. To address this need, a number of portable battery-operated potentiostats have been proposed over the years. However, most open source solutions do not take full advantage of integrated circuit (IC) potentiostats, a rapidly evolving field. This is partly due to the constraining requirements inherent to the development of dedicated interfaces, such as apps, to address and control a set of common electrochemical sensing parameters. Here we propose the PocketEC, a universal app that has all the functionalities to interface with potentiostat ICs through a user defined property file. The versatility of PocketEC, developed with an assay developer mindset, was demonstrated by interfacing it, via Bluetooth, to the ADuCM355 evaluation board, the open-source DStat potentiostat and the Voyager board, a custom-built, small footprint potentiostat based around the LMP91000 chip. The Voyager board is presented here for the first time. Data obtained using a standard redox probe, Ferrocene Carboxylic Acid (FCA) and a silver ion assay using anodic stripping multi-step amperometry were in good agreement with analogous measurements using a bench top potentiostat. Combined with its Voyager board companion, the PocketEC app can be used directly for a number of wearable or portable electrochemical sensing applications. Importantly, the versatility of the app makes it a candidate of choice for the development of future portable potentiostats. Finally, the app is available to download on the Google Play store and the source codes and design files for the PocketEC app and the Voyager board are shared via Creative Commons license (CC BY-NC 3.0) to promote the development of novel portable or wearable applications based on electrochemical sensing.

7 August 2026 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
SPSteven L. Percival
Steven L. Percival
MSMarcus Jack Swann
Marcus Jack Swann
KDKristian Daly
Kristian Daly
DMDieter O. Mayer
Dieter O. Mayer
PMPrashini Moodley
Prashini Moodley
RCRui Chen
Rui Chen
Pathogenic biofilms are a critical barrier to wound healing, driving infection persistence, delayed tissue repair, and antimicrobial resistance (AMR) and tolerance. This recognition has driven a paradigm shift from a traditional planktonic model of infection to a biofilm‐mediated framework, where structured microbial communities are encased within a protective extracellular polymeric substance (EPS) matrix. These communities are highly prevalent in chronic wounds, with reported detection rates of 60%–100% across diabetic foot ulcers, venous leg ulcers, and pressure injuries. The establishment of biofilms fundamentally alters host–microbe interactions, promotes antimicrobial tolerance, and triggers therapeutic failure, prolonged inflammation, and wound chronicity. Despite their clinical relevance, management strategies remain limited. Crucially, a lack of rapid point‐of‐care diagnostics and standardized clinical endpoints hampers timely intervention. Conventional culture based methods frequently fail to detect sessile microbial populations, necessitating advanced techniques such as next‐generation sequencing or confocal microscopy, which are largely unavailable in routine practice. A detailed understanding of the molecular and cellular mechanisms underpinning biofilm persistence is essential to translate knowledge into targeted clinical interventions. Effective management requires a biofilm centric, multimodal strategy that prioritizes regular mechanical debridement to disrupt the EPS matrix, supported by proactive exudate control and appropriate topical therapies. Looking forward, advances in diagnostic technologies, artificial intelligence (AI)‐assisted analysis, and matrix disrupting or permeating agents offer significant potential. Furthermore, emerging biological therapies, including bacteriophages, promise to help transform wound management, reduce the burden of AMR, and potentially improve patient outcomes globally.

2 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
RCRui Chen
Rui Chen
JBJeanne Saint Bezard
Jeanne Saint Bezard
MSMarcus Jack Swann
Marcus Jack Swann
FWFergus Watson
Fergus Watson
SPSteven L. Percival
Steven L. Percival
Eschar and slough in wounds serve as a reservoir for microorganisms and biofilms, damaged/devitalised cells, and inflammatory chemokines/cytokines, which work to initiate and prolong persistent inflammation and increase the risk of infection. Biofilm-related inflammation and infections are considered to be highly prevalent in acute wounds and chronic wounds. As slough is known to harbour biofilms, measuring the efficacy of antimicrobials in killing microbes both within and under slough is warranted. This highlights the need for more clinically relevant wound biofilm models to address this significant clinical need. Consequently, in this study, we developed an in vitro artificial wound slough (AWS) biofilm model produced by forming a biofilm below a layer of AWS, the latter of which was composed of the main protein components reported in wound eschar and slough, namely collagen, elastin, and fibrin. The model was employed to investigate the antibiofilm and antibacterial efficacy of a new patented smart next-generation antibiofilm technology composed of silver–zinc EDTA complexes and designed as a family of multifunctional metal complexes referred to as MMCs, in a liquid format, and to determine both the performance and penetration through AWS to control and manage biofilms. The results demonstrated the ability of the AWS–biofilm model to be employed for the evaluation of the efficacy of a new antibiofilm and antimicrobial next-generation smart technology. The results also demonstrated the potential for the proprietary EDTA multifunctional metal complexes to be used for the disruption of biofilms, such as those that form in chronic wounds.